Analyst Research

Report Title Price
Provider: Reuters Investment Profile
Provider: Plunkett Research, Ltd.
Provider: GlobalData
Provider: GlobalData

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

ImmunoVaccine Inc Reports Positive Results From Two Anthrax Studies

Monday, 9 Sep 2013 08:19am EDT 

ImmunoVaccine Inc announced positive results from anthrax challenge studies in rabbits and non-human primates using its DepoVaX delivery system. The studies showed that all animals administered a vaccine containing recombinant protective antigen (PA) formulated in DepoVax were protected against a lethal anthrax challenge. 

Company Quote

-0.09 -9.68%
29 Aug 2014